1. Home
  2. Pharma & Healthcare
  3. Global Elapegademase-lvlr Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Global Elapegademase-lvlr Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Publication Month: Sep 2021 | No. of Pages: 111 Published By: GRD Survey
Single User License: US $ 3980
Corporate User License: US $ 7960

Executive Summary

According to GRD Survey data, the global Elapegademase-lvlr market was valued at million US$ in 2020 and is expected to reach million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.

This report studies the Elapegademase-lvlr market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Elapegademase-lvlr in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Revcovi
Strimvelis
Adagen

Market Snapshot, By Application
Pediatric
Adult

Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia

Main Market Players Analyzed in this report, including:
Teijin Pharma
Orchard Therapeutics
Leadiant Biosciences

The study objectives of this report are:
To study and analyze the global Elapegademase-lvlr market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Elapegademase-lvlr market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Elapegademase-lvlr manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Elapegademase-lvlr market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Elapegademase-lvlr submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Elapegademase-lvlr are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Elapegademase-lvlr Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Elapegademase-lvlr Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter's Five Forces Analysis
2.3 Comparison of Alternatives and Elapegademase-lvlr

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Elapegademase-lvlr Sales Channel and Distributors Analysis
3.3.1 Elapegademase-lvlr Sales Channel
3.3.2 Elapegademase-lvlr Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Application One
3.4.2 Major Buyers in Application Two
3.4.1 Major Buyers in Application Three
3.5 Elapegademase-lvlr Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Elapegademase-lvlr Type Introduction
4.1.1 Revcovi
4.1.2 Strimvelis
4.1.3 Adagen
4.2 Global Elapegademase-lvlr Sales by Type 2016-2021
4.3 Global Elapegademase-lvlr Revenue by Type 2016-2021
4.4 Global Elapegademase-lvlr Price by Type 2016-2021

5 Market Segment: by Application
5.1 Elapegademase-lvlr Type Introduction
5.1.1 Pediatric
5.1.2 Adult
5.2 Global Elapegademase-lvlr Sales by Application 2016-2021
5.3 Global Elapegademase-lvlr Revenue by Application 2016-2021
5.4 Global Elapegademase-lvlr Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Elapegademase-lvlr Market by Region
6.1.1 Global Elapegademase-lvlr Sales by Regions
6.1.2 Global Elapegademase-lvlr Revenue by Regions
6.2 North America Elapegademase-lvlr Market 2016-2021
6.3 Europe Elapegademase-lvlr Market 2016-2021
6.4 Asia Pacific Elapegademase-lvlr Market 2016-2021
6.5 South America Elapegademase-lvlr Market 2016-2021
6.6 Middle East and Africa Elapegademase-lvlr Market 2016-2021

7 North America
7.1 North America Elapegademase-lvlr Market by Country 2016-2021
7.1.1 North America Elapegademase-lvlr Sales by Country
7.1.2 North America Elapegademase-lvlr Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Elapegademase-lvlr Market by Country 2016-2021
8.1.1 Europe Elapegademase-lvlr Sales by Country
8.1.2 Europe Elapegademase-lvlr Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Elapegademase-lvlr Market by Country 2016-2021
9.1.1 Asia Pacific Elapegademase-lvlr Sales by Country
9.1.2 Asia Pacific Elapegademase-lvlr Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Elapegademase-lvlr Market by Country 2016-2021
10.1.1 South America Elapegademase-lvlr Sales by Country
10.1.2 South America Elapegademase-lvlr Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Elapegademase-lvlr Market by Country 2016-2021
11.1.1 Middle East and Africa Elapegademase-lvlr Sales by Country
11.1.2 Middle East and Africa Elapegademase-lvlr Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Teijin Pharma
12.1.1 Teijin Pharma Company Information
12.1.2 Teijin Pharma Elapegademase-lvlr Product Portfolio, Specification and Application
12.1.3 Teijin Pharma Elapegademase-lvlr Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Teijin Pharma Key Development
12.2 Orchard Therapeutics
12.2.1 Orchard Therapeutics Company Information
12.2.2 Orchard Therapeutics Elapegademase-lvlr Product Portfolio, Specification and Application
12.2.3 Orchard Therapeutics Elapegademase-lvlr Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Orchard Therapeutics Key Development
12.3 Leadiant Biosciences
12.3.1 Leadiant Biosciences Company Information
12.3.2 Leadiant Biosciences Elapegademase-lvlr Product Portfolio, Specification and Application
12.3.3 Leadiant Biosciences Elapegademase-lvlr Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Leadiant Biosciences Key Development

13 Global Elapegademase-lvlr Market Forecast by Region by Type and by Application
13.1 Global Elapegademase-lvlr Sales, Revenue Forecast 2022-2027
13.2 Global Elapegademase-lvlr Forecast by Regions
13.2.1 Global Elapegademase-lvlr Sales Forecast by Region 2022-2027
13.2.2 Global Elapegademase-lvlr Revenue Forecast by Region 2022-2027
13.3 Global Elapegademase-lvlr Forecast by Type
13.3.1 Global Elapegademase-lvlr Sales Forecast by Type 2022-2027
13.3.2 Global Elapegademase-lvlr Revenue Forecast by Type 2022-2027
13.3.3 Global Elapegademase-lvlr Price Forecast by Type 2022-2027
13.4 Global Elapegademase-lvlr Forecast by Application
13.4.1 Global Elapegademase-lvlr Sales Forecast by Application 2022-2027
13.4.2 Global Elapegademase-lvlr Revenue Forecast by Application 2022-2027
13.4.3 Global Elapegademase-lvlr Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer


List of Tables

Table 1: Global Elapegademase-lvlr Production Specifications
Table 2: Drivers in Elapegademase-lvlr Market
Table 3: Restraints Elapegademase-lvlr Market
Table 4: Opportunity in Elapegademase-lvlr Market
Table 5: Comparion of Alternative and Elapegademase-lvlr
Table 6: Elapegademase-lvlr Raw Materials Key Suppliers List
Table 7: Elapegademase-lvlr Distributors List
Table 8: Elapegademase-lvlr Major Buyers in Application One
Table 9: Elapegademase-lvlr Major Buyers in Application Two
Table 10: Elapegademase-lvlr Major Buyers in Application Three
Table 11: Global Elapegademase-lvlr Sales (K Units) by Type 2016-2021
Table 12: Global Elapegademase-lvlr Sales Market Share by Type 2016-2021
Table 13: Global Elapegademase-lvlr Revenue (Million USD) by Type 2016-2021
Table 14: Global Elapegademase-lvlr Revenue Market Share by Type 2016-2021
Table 15: Global Elapegademase-lvlr Price by Type 2016-2021
Table 16: Global Elapegademase-lvlr Sales (K Units) by Application 2016-2021
Table 17: Global Elapegademase-lvlr Sales Market Share by Application 2016-2021
Table 18: Global Elapegademase-lvlr Revenue (Million USD) by Application 2016-2021
Table 19: Global Elapegademase-lvlr Revenue Market Share by Application 2016-2021
Table 20: Global Elapegademase-lvlr Price by Application 2016-2021
Table 21: Global Elapegademase-lvlr Sales (K Units) by Region 2016-2021
Table 22: Global Elapegademase-lvlr Sales Market Share by Region 2016-2021
Table 23: Global Elapegademase-lvlr Revenue (Million USD) by Region 2016-2021
Table 24: Global Elapegademase-lvlr Revenue Market Share by Region 2016-2021
Table 25: North America Elapegademase-lvlr Sales (K Units) by Country 2016-2021
Table 26: North America Elapegademase-lvlr Sales Market Share by Country 2016-2021
Table 27: North America Elapegademase-lvlr Revenue (Million USD) by Country 2016-2021
Table 28: North America Elapegademase-lvlr Revenue Market Share by Country 2016-2021)
Table 29: Europe Elapegademase-lvlr Sales (K Units) by Country 2016-2021
Table 30: Europe Elapegademase-lvlr Sales Market Share by Country 2016-2021
Table 31: Europe Elapegademase-lvlr Revenue (Million USD) by Country 2016-2021
Table 32: Europe Elapegademase-lvlr Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Elapegademase-lvlr Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Elapegademase-lvlr Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Elapegademase-lvlr Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Elapegademase-lvlr Revenue Market Share by Country 2016-2021)
Table 37: South America Elapegademase-lvlr Sales (K Units) by Country 2016-2021
Table 38: South America Elapegademase-lvlr Sales Market Share by Country 2016-2021
Table 39: South America Elapegademase-lvlr Revenue (Million USD) by Country 2016-2021
Table 40: South America Elapegademase-lvlr Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Elapegademase-lvlr Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Elapegademase-lvlr Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Elapegademase-lvlr Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Elapegademase-lvlr Revenue Market Share by Country 2016-2021)
Table 45 Teijin Pharma Company Information
Table 46 Teijin Pharma Elapegademase-lvlr Product Portfolio, Specification and Application
Table 47 Teijin Pharma Elapegademase-lvlr Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Orchard Therapeutics Company Information
Table 49 Orchard Therapeutics Elapegademase-lvlr Product Portfolio, Specification and Application
Table 50 Orchard Therapeutics Elapegademase-lvlr Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 Leadiant Biosciences Company Information
Table 52 Leadiant Biosciences Elapegademase-lvlr Product Portfolio, Specification and Application
Table 53 Leadiant Biosciences Elapegademase-lvlr Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Elapegademase-lvlr Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Elapegademase-lvlr Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Elapegademase-lvlr Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Elapegademase-lvlr Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Elapegademase-lvlr Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Elapegademase-lvlr Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Elapegademase-lvlr Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Elapegademase-lvlr Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Elapegademase-lvlr Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Elapegademase-lvlr Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Elapegademase-lvlr Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Elapegademase-lvlr Revenue Market Share Forecast by Application (2022-2027)

Tables and Figures

List of Figures

Figure 1: Elapegademase-lvlr Picture
Figure 2: Global Elapegademase-lvlr Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Elapegademase-lvlr Supply Chain Analysis
Figure 5: Elapegademase-lvlr Manufacturing Cost Structure Analysis
Figure 6: Product Picture of Revcovi
Figure 7: Product Picture of Strimvelis
Figure 8: Global Elapegademase-lvlr Sales Market Share by Type, 2020
Figure 9: Global Elapegademase-lvlr Revenue Market Share by Type, 2020
Figure 10: Elapegademase-lvlr in Pediatric
Figure 11: Global Elapegademase-lvlr Market: Pediatric 2016-2021
Figure 12: Elapegademase-lvlr in Adult
Figure 13: Global Elapegademase-lvlr Market: Adult 2016-2021
Figure 14: Global Elapegademase-lvlr Sales Market Share by Application, 2020
Figure 15: Global Elapegademase-lvlr Revenue Market Share by Application, 2020
Figure 16: Global Elapegademase-lvlr Sales Market Share by Region 2016-2021
Figure 17: Global Elapegademase-lvlr Revenue Market Share by Region 2016-2021
Figure 18: North America Elapegademase-lvlr Sales (K Units) Status 2016-2021
Figure 19: North America Elapegademase-lvlr Revenue (Million USD) Status 2016-2021
Figure 20: Europe Elapegademase-lvlr Sales (K Units) Status 2016-2021
Figure 21: Europe Elapegademase-lvlr Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Elapegademase-lvlr Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Elapegademase-lvlr Revenue (Million USD) Status 2016-2021
Figure 24: South America Elapegademase-lvlr Sales (K Units) Status 2016-2021
Figure 25: South America Elapegademase-lvlr Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Elapegademase-lvlr Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Elapegademase-lvlr Revenue (Million USD) Status 2016-2021
Figure 28: North America Elapegademase-lvlr Sales Market Share by Country, 2020
Figure 29: North America Elapegademase-lvlr Revenue Market Share by Country, 2020
Figure 30: United States Elapegademase-lvlr Sales (K Units) Status 2016-2021
Figure 31: United States Elapegademase-lvlr Revenue (Million USD) Status 2016-2021
Figure 32: Canada Elapegademase-lvlr Sales (K Units) Status 2016-2021
Figure 33: Canada Elapegademase-lvlr Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Elapegademase-lvlr Sales (K Units) Status 2016-2021
Figure 35: Mexico Elapegademase-lvlr Revenue (Million USD) Status 2016-2021
Figure 36: Europe Elapegademase-lvlr Sales Market Share by Country, 2020
Figure 37: Europe Elapegademase-lvlr Revenue Market Share by Country, 2020
Figure 38: Germany Elapegademase-lvlr Sales (K Units) Status 2016-2021
Figure 39: Germany Elapegademase-lvlr Revenue (Million USD) Status 2016-2021
Figure 40: France Elapegademase-lvlr Sales (K Units) Status 2016-2021
Figure 41: France Elapegademase-lvlr Revenue (Million USD) Status 2016-2021
Figure 42: UK Elapegademase-lvlr Sales (K Units) Status 2016-2021
Figure 43: UK Elapegademase-lvlr Revenue (Million USD) Status 2016-2021
Figure 44: Italy Elapegademase-lvlr Sales (K Units) Status 2016-2021
Figure 45: Italy Elapegademase-lvlr Revenue (Million USD) Status 2016-2021
Figure 46: Russia Elapegademase-lvlr Sales (K Units) Status 2016-2021
Figure 46: Russia Elapegademase-lvlr Revenue (Million USD) Status 2016-2021
Figure 47: Spain Elapegademase-lvlr Sales (K Units) Status 2016-2021
Figure 48: Spain Elapegademase-lvlr Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Elapegademase-lvlr Sales Market Share by Country, 2020
Figure 50: Asia Pacific Elapegademase-lvlr Revenue Market Share by Country, 2020
Figure 51: China Elapegademase-lvlr Sales (K Units) Status 2016-2021
Figure 52: China Elapegademase-lvlr Revenue (Million USD) Status 2016-2021
Figure 53: Japan Elapegademase-lvlr Sales (K Units) Status 2016-2021
Figure 54: Japan Elapegademase-lvlr Revenue (Million USD) Status 2016-2021
Figure 55: Korea Elapegademase-lvlr Sales (K Units) Status 2016-2021
Figure 56: Korea Elapegademase-lvlr Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Elapegademase-lvlr Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Elapegademase-lvlr Revenue (Million USD) Status 2016-2021
Figure 59: India Elapegademase-lvlr Sales (K Units) Status 2016-2021
Figure 60: India Elapegademase-lvlr Revenue (Million USD) Status 2016-2021
Figure 61: Australia Elapegademase-lvlr Sales (K Units) Status 2016-2021
Figure 62: Australia Elapegademase-lvlr Revenue (Million USD) Status 2016-2021
Figure 63: South America Elapegademase-lvlr Sales Market Share by Country, 2020
Figure 64: South America Elapegademase-lvlr Revenue Market Share by Country, 2020
Figure 65: Brazil Elapegademase-lvlr Sales (K Units) Status 2016-2021
Figure 66: Brazil Elapegademase-lvlr Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Elapegademase-lvlr Sales (K Units) Status 2016-2021
Figure 68: Argentina Elapegademase-lvlr Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Elapegademase-lvlr Sales (K Units) Status 2016-2021
Figure 70: Colombia Elapegademase-lvlr Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Elapegademase-lvlr Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Elapegademase-lvlr Revenue Market Share by Country, 2020
Figure 73: Turkey Elapegademase-lvlr Sales (K Units) Status 2016-2021
Figure 74: Turkey Elapegademase-lvlr Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Elapegademase-lvlr Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Elapegademase-lvlr Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Elapegademase-lvlr Sales (K Units) Status 2016-2021
Figure 78: South Africa Elapegademase-lvlr Revenue (Million USD) Status 2016-2021
Figure 79: Teijin Pharma Elapegademase-lvlr Revenue Market Share Globally (2019-2021)
Figure 80: Orchard Therapeutics Elapegademase-lvlr Revenue Market Share Globally (2019-2021)
Figure 81: Leadiant Biosciences Elapegademase-lvlr Revenue Market Share Globally (2019-2021)
Figure 89: Global Elapegademase-lvlr Sales (K Units) Forecast (2022-2027)
Figure 90: Global Elapegademase-lvlr Sales (K Units) Forecast (2022-2027)


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets